Should we move beyond VEGF inhibition in metastatic colorectal cancer? Lessons from early phase clinical trials
Patel, Sukeshi R, Karnad, Anand B, Ketchum, Norma S, Pollock, Brad H, Sarantopoulos, John, Weitman, Steven, Mahalingam, Devalingam
Published in Journal of gastrointestinal oncology (01.04.2014)
Published in Journal of gastrointestinal oncology (01.04.2014)
Get full text
Journal Article
Impact of universal screening of colorectal cancer (CRC) for detection of Lynch syndrome (LS) at a Hispanic-predominant county hospital
Snedden, Tyler William, McCracken, Andrew, Vaidyanathan, Anusha, McGruder, Carla, Taranova, Anna, Villarreal, Roberto, Patel, Sukeshi R.
Published in Journal of clinical oncology (10.03.2017)
Published in Journal of clinical oncology (10.03.2017)
Get full text
Journal Article
Clinicopathologic differences and survival of Hispanics (H) versus Non-Hispanic Whites (NHW) with gastric cancer (GC) at a Majority Minority Cancer Center in South Texas
Barron, Cesar Ivan, Hernandez, Brian, Mahalingam, Devalingam, Michalek, Joel, Patel, Sukeshi R.
Published in Journal of clinical oncology (01.02.2017)
Published in Journal of clinical oncology (01.02.2017)
Get full text
Journal Article
Left versus right: Does location matter for refractory metastatic colorectal cancer (mCRC) patients in phase I clinical trials?
Patel, Sukeshi R., Ketchum, Norma S., Michalek, Joel, Gelfond, Jonathan, Mahalingam, Devalingam
Published in Journal of clinical oncology (01.02.2017)
Published in Journal of clinical oncology (01.02.2017)
Get full text
Journal Article
Effect of vorinostat (VOR) and hydroxychloroquine (HCQ) on immunity and autophagy in metastatic colorectal cancer (mCRC)
Patel, Sukeshi R., Hurez, Vincent, Nawrocki, Steffan T, Goros, Martin, Michalek, Joel, Sarantopoulos, John, Curiel, Tyler J., Mahalingam, Devalingam
Published in Journal of clinical oncology (01.02.2016)
Published in Journal of clinical oncology (01.02.2016)
Get full text
Journal Article
Delays in treatment for colorectal cancer patients in an NCI-designated cancer center serving a Hispanic majority community
Wangjam, Tamna, Rauenzahn, Sherri L., Iruku, Praveena, Lindauer, Stephanie Purkat, Butler, Matthew James, Hung, Annie, Yarta, Kinan, Jones, Jessica Trevino, Konkel, Brandon, McCracken, Andrew, Patel, Sukeshi R.
Published in Journal of clinical oncology (10.03.2017)
Published in Journal of clinical oncology (10.03.2017)
Get full text
Journal Article
Risks and benefits of phase I liver dysfunction studies: Should patients with severe liver dysfunction be included in these trials?
Stuart, Selena Juarez, Sarantopoulos, John, Karnad, Anand B., Mahalingam, Devalingam, Patel, Sukeshi R., Weitman, Steven D.
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article
Safety of sorafenib (SOR) dose in United States (US) patients (pts) with advanced hepatocellular carcinoma (HCC) with varying liver dysfunction: Lessons from a Hispanic-rich South Texas institution
Patel, Sukeshi R., Al-Rajabi, Raed Moh'd Taiseer, Ketchum, Norma S., Lu, Ting-Wei, Michalek, Joel, Mahalingam, Devalingam
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article
Comparative efficacy of sorafenib dose in patients with advanced hepatocellular carcinoma (HCC) with varying liver dysfunction
Patel, Sukeshi R., Al-Rajabi, Raed Moh'd Taiseer, Ketchum, Norma, Lu, Ting-Wei, Pollock, Brad H., Michalek, Joel, Mahalingam, Devalingam
Published in Journal of clinical oncology (20.01.2015)
Published in Journal of clinical oncology (20.01.2015)
Get full text
Journal Article
Beyond VEGF inhibition: Comparative efficacy analysis of novel VEGF and non-VEGF therapeutic agents in phase I trials for patients with metastatic colorectal cancer (mCRC)
Patel, Sukeshi R., Ketchum, Norma, Pollock, Brad H., Sarantopoulos, John, Weitman, Steven, Mahalingam, Devalingam
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article
Abstract A3: Beyond VEGF inhibition: Comparative efficacy analysis of novel VEGF and non-VEGF therapeutic agents in phase I trials for patients with metastatic colorectal cancer
Patel, Sukeshi R., Karnad, Anand B., Ketchum, Norma S., Pollock, Brad H., Sarantopoulos, John, Weitman, Steven, Mahalingam, Devalingam
Published in Molecular cancer therapeutics (01.11.2013)
Published in Molecular cancer therapeutics (01.11.2013)
Get full text
Journal Article